(Q48700718)

14 February 2018

title

Differential regulation of dopamine receptors after chronic typical and atypical antipsychotic drug treatment. (English)

1 reference

14 February 2018

0 references

Tarazi FI

1

1 reference

14 February 2018

Florijn WJ

series ordinal

2

1 reference

14 February 2018

Creese I

series ordinal

3

1 reference

14 February 2018

language of work or name

English

0 references

publication date

1 June 1997

1 reference

14 February 2018

published in

Neuroscience

1 reference

14 February 2018

volume

78

1 reference

14 February 2018

issue

4

1 reference

14 February 2018

page(s)

985-996

1 reference

14 February 2018

The functional anatomy of basal ganglia disorders

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Functional architecture of basal ganglia circuits: neural substrates of parallel processing

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Dopamine neurochemical profile of atypical antipsychotics resembles that of D-1 antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Serotonin2 (5-HT2) receptor binding in the frontal cortex of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Brain dopamine receptors: a primer on their current status, basic and clinical

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Dopaminergic innervation of the cerebral cortex: unexpected differences between rodents and primates

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Dopamine D1 (SCH 23390) and D2 (haloperidol) antagonists in drug-naive monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Molecular diversity of the dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Expression of rat striatal D1 and D2 dopamine receptor mRNAs: ontogenetic and pharmacological studies

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

3H-Spiroperidol labels serotonin receptors in rat cerebral cortex and hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

D-1 dopamine receptors in the rat brain: a quantitative autoradiographic analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

The involvement of dopamine D1 and D2 receptors in the effects of the classical neuroleptic haloperidol and the atypical neuroleptic clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Selective D1- and D2-dopamine receptor blockade both induces akathisia in humans--a PET study with [11C]SCH 23390 and [11C]raclopride

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

An open label trial of raclopride in acute schizophrenia. Confirmation of D2-dopamine receptor occupancy by PET

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Effects of chronic discontinuous and continuous treatment of rats with a dopamine D1 receptor antagonist (NNC-756)

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

[3H]7-OH-DPAT is capable of labeling dopamine D2 as well as D3 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Dopamine D1 receptor antagonism in schizophrenia: is there reduced risk of extrapyramidal side-effects?

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Striatal D2 dopamine receptor characteristics in neuroleptic-naive schizophrenic patients studied with positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Autoradiographic visualization of dopamine D-2 receptors in the monkey brain using the selective benzamide drug [3H]raclopride.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Long-term treatment with haloperidol or clozapine does not affect dopamine D4 receptors in rat frontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

D2-family receptor distribution in human postmortem tissue: an autoradiographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

A paradoxical regulation of the dopamine D3 receptor expression suggests the involvement of an anterograde factor from dopamine neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

A common action of clozapine, haloperidol, and remoxipride on D1- and D2-dopaminergic receptors in the primate cerebral cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Distribution of D5 dopamine receptor mRNA in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Distribution of putative D4 dopamine receptors in postmortem striatum from patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Chronic treatment with clozapine or haloperidol differentially regulates dopamine and serotonin receptors in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

[3H]Spiperone binding sites in brain: autoradiographic localization of multiple receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

[3H]SCH 23390 binding sites increase after chronic blockade of D-1 dopamine receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Are Striatal Dopamine D4 Receptors Increased in Schizophrenia?

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Absence of detectable striatal dopamine D4 receptors in drug-treated schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Chronic treatment with clozapine, unlike haloperidol, does not induce changes in striatal D-2 receptor function in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Long-term haloperidol elevates dopamine D4 receptors by 2-fold in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Autoradiographic analysis of regional alterations in brain receptors following chronic administration and withdrawal of typical and atypical neuroleptics in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Dopamine D4 receptors elevated in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Schizophrenia: elevation of dopamine D4-like sites, using [3H]nemonapride and [125I]epidepride

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Antipsychotic drug doses and neuroleptic/dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Dopamine D4-like receptor elevation in schizophrenia: cloned D2 and D4 receptors cannot be discriminated by raclopride competition against [3H]nemonapride

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Basal ganglia GABAA and dopamine D1 binding site correlates of haloperidol-induced oral dyskinesias in rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Molecular biology of dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Dopamine D4 receptors and effects of guanine nucleotides on [3H]raclopride binding in postmortem caudate nucleus of subjects with schizophrenia or major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Genomic structure and tissue distribution of the mouse dopamine D4 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Mechanisms of signal transduction at the dopamine D2 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Lack of effect of chronic dopamine receptor blockade on D2 dopamine receptor mRNA level

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

Autoradiographic distribution of [3H]YM-09151-2, a high-affinity and selective antagonist ligand for the dopamine D2 receptor group, in the rat brain and spinal cord.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900631-8

7 January 2021

10.1016/S0306-4522(96)00631-8

Identifiers

DOI

1 reference

14 February 2018

PubMed ID

9174067

1 reference

14 February 2018